Free-text search
Content Types
-
BioArctic steps into cancer research with new collaboration
BioArctic has entered a research collaboration with the Swedish‑Japanese company Mesenkia Therapeutics, marking the company’s first step into the oncology field.
-
New FDA setback for Xspray – stock plunges
The Swedish research company Xspray Pharma has received yet another negative decision from the U.S. Food and Drug Administration (FDA), linked to the company’s ...
-
Trump expected to pick Heidi Overton to lead the FDA
Donald Trump is expected to nominate Heidi Overton as the new commissioner of the US Food and Drug Administration (FDA), according to several international media outlets.
-
LEO Pharma acquires dermatology drug for 435 million USD
LEO Pharma strengthens its dermatology portfolio by acquiring the late-stage drug candidate dersimelagon.
-
Pila Pharma cleared to begin obesity trial
Swedish–Danish Pila Pharma has received approval from the European Medicines Agency (EMA) to begin a clinical trial of the company’s drug candidate for obesity.
-
Life sciences fuel Greater Copenhagen's economic growth
The expansion of the life sciences sector on the Danish side of the Øresund is a key reason why the Danish-Swedish Greater Copenhagen region has emerged as one ...
-
Sanofi cuts 229 jobs following $9.1bn acquisition
A new round of job cuts is hitting the US biotech hub of Massachusetts. Sanofi is cutting 229 positions and closing former Blueprint offices, while Merck KGaA i...
-
Evaxion drops solid tumour vaccine to advance new glioblastoma program
Danish biotech company Evaxion is discontinuing a vaccine candidate for solid tumors and redirecting resources to a program specifically aimed at brain cancer.
-
CAR‑T developer Elicera appoints new CEO
Swedish CAR‑T developer Elicera has appointed Johan Liwing as its new CEO, succeeding Jamal El‑Mosleh, who is stepping down.
-
Potions, Placebos and Perilous Practices – Macabre Mistakes in the History of Medicine
Tobacco for cancer, heroin for coughs, mercury for teething babies. Humanity’s path towards today’s evidence‑based medicine has been lined with strange misjudge...
-
OCTONIQ, Ett smart, modulärt CIP-system.
OCTONIQ, ett modulärt CIP-system från AxFlow Systems som effektivt rengör din anläggning med hög precision. Systemet minskar förbrukningen av både vatten, energ...
-
“Ozempic babies” – myth or reality?
Have weight-loss drugs such as Ozempic led to a rise in unplanned pregnancies? Life Science Sweden takes a closer look.
-
Hacker group claims Chinese bid for stolen Novo data
Earlier this year, Novo Nordisk was hit by a high‑profile data breach in which a large amount of sensitive information was stolen. Now a hacker group claims tha...
-
ZEISS Innovation Summit returns to Berlin
Gain insights from experts for future-ready quality assurance.
-
Lantheus challenges Eli Lilly with FDA-approved Alzheimer’s tracer
Eli Lilly has until now had the US market for tau PET imaging in Alzheimer’s disease to itself. The pharmaceutical giant is now facing competition after the FDA...
-
AstraZeneca scraps late‑stage study – and reports dual successes in lung cancer
AstraZeneca is discontinuing a global Phase III trial that has been evaluating the antibody volrustimig for non‑small cell lung cancer after the chances of succ...
-
Ensuring Safety and Compliance for IVD Products
In vitro diagnostic medical devices (IVDs) play a crucial role in diagnosis and treatment, as a significant proportion of healthcare decisions are based on labo...
-
Life Science Nordic launches – bringing Nordic life science news under one roof
Welcome to Life Science Nordic – your source for the news and insights shaping the Nordic life science and medtech industries. We provide independent, in-depth ...
-
Hansa chair: “Too many boards spend far too much time looking inwards”
Following a change of chief executive and a sharper strategic focus, Hansa Biopharma is entering a decisive phase in the US market. As the company prepares for ...
-
Gold Rush in Oral Peptides: “Everybody Wants In”
After Ozempic, pharmaceutical companies are racing toward the next big revolution: peptides that can be swallowed as easily as they can be injected. Cyprumed is...
-
EMA opens review of Europe’s first potential Lyme disease vaccine
The European Medicines Agency (EMA) has validated Valneva’s and Pfizer’s application for approval of the companies’ Lyme disease vaccine, meaning it is now read...
-
Tuff vecka för Fresenius Kabi – dubbla återkallanden
Fresenius Kabi återkallar ett parti av en av sina biosimilarer i USA sedan produkten visat sig innehålla glaspartiklar. Missen uppdagades bara en vecka efter at...
-
Ny finanschef till Biolamina
Biotechbolaget Biolamina, verksamt inom cellodling och stamcellsteknik, har rekryterat Sofia Helgesson som finanschef (CFO).
-
Thermo Fishers mikrobiologiverksamhet byter ägare
Thermo Fisher har nu genomfört försäljningen av sin mikrobiologienhet till ett privat riskkapitalbolag, som kommer att driva verksamheten vidare som ett självständigt bolag.
BREAKING